Hiroshi Hinou Selected Research

prolyl-prolyl-alanine

1/2013

Site-specific conformational alteration induced by sialylation of MUC1 tandem repeating glycopeptides at an epitope region for the anti-KL-6 monoclonal antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Hinou Research Topics

Disease

19	Neoplasms (Cancer) 11/2020 - 01/2007
5	Breast Neoplasms (Breast Cancer) 03/2020 - 12/2009
3	Neoplasm Metastasis (Metastasis) 04/2020 - 02/2011
3	Inflammation (Inflammations) 01/2013 - 02/2011
2	Adenocarcinoma 04/2020 - 12/2009
2	Carcinoma (Carcinomatosis) 01/2020 - 03/2014
2	Human Influenza (Influenza) 12/2019 - 06/2013
2	Central Nervous System Diseases (CNS Diseases) 08/2016 - 09/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2016 - 09/2015
2	Adenocarcinoma of Lung 02/2016 - 12/2009
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2016 - 12/2009
2	Infections 06/2013 - 08/2010
2	Carcinogenesis 01/2013 - 02/2011
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 12/2017
1	Alzheimer Disease (Alzheimer's Disease) 08/2016
1	Huntington Disease (Huntington's Disease) 09/2015
1	Communicable Diseases (Infectious Diseases) 06/2013
1	Chagas Disease (American Trypanosomiasis) 08/2010
1	Hepatocellular Carcinoma (Hepatoma) 12/2009
1	Virus Diseases (Viral Diseases) 01/2007
1	Cholera 09/2005

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2007
9	Polysaccharides (Glycans)IBA 04/2020 - 01/2013
5	AntibodiesIBA 11/2020 - 12/2017
5	GlycopeptidesIBA 01/2020 - 01/2013
5	EpitopesIBA 01/2020 - 12/2009
5	Glycoproteins (Glycoprotein)IBA 08/2018 - 12/2009
4	Proteins (Proteins, Gene)FDA Link 04/2020 - 01/2007
3	Peptides (Polypeptides)IBA 04/2020 - 02/2011
3	MucinsIBA 04/2020 - 02/2011
3	Tn antigenIBA 03/2020 - 10/2015
3	Mucin-1 (CA 15-3 Antigen)IBA 01/2020 - 12/2009
3	AntigensIBA 01/2020 - 12/2009
3	Monoclonal AntibodiesIBA 10/2015 - 03/2014
2	CarbohydratesIBA 04/2020 - 03/2020
2	Immunoglobulin G (IgG)IBA 03/2020 - 06/2019
2	VaccinesIBA 03/2020 - 10/2015
2	AutoantibodiesIBA 01/2020 - 01/2020
2	LigandsIBA 01/2017 - 02/2016
2	Epidermal Growth Factor (EGF)IBA 01/2017 - 02/2016
2	Pharmaceutical PreparationsIBA 08/2016 - 08/2010
2	alanylprolineIBA 01/2016 - 01/2013
2	arginylprolineIBA 01/2016 - 01/2013
2	Biological ProductsIBA 01/2013 - 12/2010
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 08/2010 - 09/2005
1	Threonine (L-Threonine)FDA Link 01/2020
1	Notch1 ReceptorIBA 01/2017
1	KetonesIBA 09/2015
1	Phosphorylcholine (Phosphocholine)IBA 09/2015
1	His-His-His-His-His-His ((His)6)IBA 09/2015
1	Arginine (L-Arginine)FDA Link 09/2015
1	gamma-Aminobutyric Acid (GABA)IBA 09/2015
1	Peptide FragmentsIBA 03/2014
1	Hemagglutinins (Hemagglutinin)IBA 06/2013
1	OligosaccharidesIBA 02/2013
1	Hyaluronic Acid (Hyaluronan)IBA 02/2013
1	histidylglycineIBA 01/2013
1	prolyl-prolyl-alanineIBA 01/2013
1	alanyl-prolyl-glycineIBA 01/2013
1	Proteoglycans (Proteoglycan)IBA 09/2012
1	N-AcetylgalactosaminyltransferasesIBA 02/2011
1	Uridine Diphosphate (UDP)IBA 02/2011
1	ParaffinIBA 12/2010
1	Formaldehyde (Formol)FDA Link 12/2010
1	2- difluoromethyl- 4- nitrophenyl- 3,5- dideoxygalacto- 2- nonulopyranosid acidIBA 08/2010
1	trans-sialidaseIBA 08/2010
1	Cancer VaccinesIBA 12/2009
1	Cholera ToxinIBA 09/2005
1	GangliosidesIBA 09/2005
1	Neuraminidase (Sialidase)IBA 09/2005

Therapy/Procedure

1	Therapeutics 01/2020
1	Ligation 09/2015
1	Drug Therapy (Chemotherapy) 08/2010